Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-4 of 4 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2018Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: the SIMPLIFY studyCunningham, E.B.; Amin, J.; Feld, J.J.; Bruneau, J.; Dalgard, O.; Powis, J.; Hellard, M.; Cooper, C.; Read, P.; Conway, B.; Dunlop, A.J.; Norton, B.; Litwin, A.H.; Hajarizadeh, B.; Thurnheer, M.C.; Dillon, J.F.; Weltman, M.; Shaw, D.; Bruggmann, P.; Gane, E.; et al.
2018Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapyGrebely, J.; Conway, B.; Cunningham, E.B.; Fraser, C.; Moriggia, A.; Gane, E.; Stedman, C.; Cooper, C.; Castro, E.; Schmid, P.; Petoumenos, K.; Hajarizadeh, B.; Marks, P.; Erratt, A.; Dalgard, O.; Lacombe, K.; Feld, J.J.; Bruneau, J.; Daulouede, J.P.; Powis, J.; et al.
2015Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis CAlavi, M.; Spelman, T.; Matthews, G.V.; Haber, P.S.; Day, C.; van Beek, I.; Walsh, N.; Yeung, B.; Bruneau, J.; Petoumenos, K.; Dolan, K.; Kaldor, J.M.; Dore, G.J.; Hellard, M.; Grebely, J.; Marks, P.; Amin, J.; Doab, A.; Carroll, T.; Teutsch, S.; et al.
2018Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trialGrebely, J.; Dalgard, O.; Conway, B.; Cunningham, E.B.; Bruggmann, P.; Hajarizadeh, B.; Amin, J.; Bruneau, J.; Hellard, M.; Litwin, A.H.; Marks, P.; Quiene, S.; Siriragavan, S.; Applegate, T.L.; Swan, T.; Byrne, J.; Lacalamita, M.; Dunlop, A.; Matthews, G.V.; Powis, J.; et al.